- In connection with the implementation of the project titled „Design and development of an innovative solution – a complex, three-component medicinal product targeting the treatment of hypertension”, financed from the state budget funds from the Medical Research Agency, Zakłady Farmaceutyczne „Polpharma” S.A., requests that you submit bids concerning the purchase and supply an active substance from the group of ACE inhibitors that undergoes metabolism in the body into a long-acting active metabolite, ramiprilat. Details of the price inquiry can be found in the documents attached below.